Ajinomoto’s North Carolina Plant Receives ISO 9001 Certification

  Ajinomoto’s North Carolina Plant Receives ISO 9001 Certification

   Certification reinforces Ajinomoto’s commitment to providing the highest
            standards of product quality and customer satisfaction

Business Wire

RALEIGH, N.C. -- May 6, 2013

Ajinomoto North America, Inc. today announced it has received ISO 9001
certification at its North Carolina plant. ISO 9001 is an ISO (International
Organization for Standardization) program with voluntary standards that aims
to acknowledge specifications for products, services and good practices.
Practicing ISO 9001 standards reinforces Ajinomoto North America’s dedication
to producing high quality products and providing exceptional service to its
customers.

The two-year application process required several plant updates including
improvements to the Training Management System (TMS) and Corrective and
Preventative Action (CAPA) system. By obtaining ISO 9001 certification,
Ajinomoto guarantees its commitment to efficient work practices and business
objectives, resulting in easily defined responsibilities, reduced costs and
increased customer satisfaction, amongst other benefits.

Ajinomoto was the first manufacturer to produce pharmaceutical grade amino
acids and continues to be the only pharmaceutical L-amino acid manufacturer in
the United States. Its North Carolina plant previously obtained its Good
Manufacturing Practices (cGMP) certificate from the FDA, which ensures
regulatory review and inspection policies based upon adoption of the latest
technological advances within the pharmaceutical industry.

“We aim to provide the highest quality practices and processes for all of our
product lines throughout the entire manufacturing process,” said Mike Lish,
vice president of Ajinomoto North America. “The ISO 9001 certification
benefits our business partners, bulk purchasers and bio teams. In addition, it
demonstrates our dedication to the Ajinomoto Group Way, which expresses the
values shared among all the companies of the Ajinomoto Group.”

Please visit www.ajiaminoscience.com to learn more about Ajinomoto’s
dedication to the quality and safety of its patented amino acid production
technology and practices.

About Ajinomoto North America, Inc.

Ajinomoto is the leading global supplier of pharmaceutical and research-grade
amino acids. Leveraging its unrivaled foundation of more than 50 years
experience identifying, refining, and marketing amino acids, Ajinomoto North
America, Inc. continues to innovate and set new industry standards for
manufacturing and related services within the fermentation and expression
fields. Building on its legacy, Amino Acid Technologies has transitioned the
same level of quality and performance into new core competencies in the areas
of recombinant protein expression and peptide synthesis. These new processes
enable pharmaceutical and biotech companies to develop high-quality products
that were previously thought to be too complicated or expensive to produce.
Ajinomoto North America, Inc. is a wholly-owned subsidiary of Ajinomoto Co.,
Inc. For more information, please refer to
http://www.ajiaminoscience.com/Default.aspx##.

Contact:

Crossroads Public Relations for Ajinomoto North America, Inc.
Molly Thompson, 919-821-2822
aji@crossroadspr.com
Mobile:919-605-0022
 
Press spacebar to pause and continue. Press esc to stop.